Opioid-related deaths between 2019 and 2021 across 9 Canadian provinces and territories

Shaleesa Ledlie, David Juurlink, Mina Tadrous, M. Mamdani, J. M. Paterson, Tara Gomes
{"title":"Opioid-related deaths between 2019 and 2021 across 9 Canadian provinces and territories","authors":"Shaleesa Ledlie, David Juurlink, Mina Tadrous, M. Mamdani, J. M. Paterson, Tara Gomes","doi":"10.1503/cmaj.231339","DOIUrl":null,"url":null,"abstract":"Background: The drug toxicity crisis continues to accelerate across Canada, with rapid increases in opioid-related harms following the onset of the COVID-19 pandemic. We sought to describe trends in the burden of opioid-related deaths across Canada throughout the pandemic, comparing these trends by province or territory, age, and sex. Methods: We conducted a repeated cross-sectional analysis of accidental opioid-related deaths between Jan. 1, 2019, and Dec. 31, 2021, across 9 Canadian provinces and territories using aggregated national data. Our primary measure was the burden of premature opioid-related death, measured by potential years of life lost. Our secondary measure was the proportion of all deaths attributable to opioids; we used the Cochrane–Armitage test for trend to compare proportions. Results: Between 2019 and 2021, the annual number of opioid-related deaths increased from 3007 to 6222 and years of life lost increased from 126 115 to 256 336 (from 3.5 to 7.0 yr of life lost per 1000 population). In 2021, the highest number of years of life lost was among males (181 525 yr) and people aged 30–39 years (87 045 yr). In 2019, we found that 1.7% of all deaths among those younger than 85 years were related to opioids, rising to 3.2% in 2021. Significant increases in the proportion of deaths related to opioids were observed across all age groups (p < 0.001), representing 29.3% and 29.0% of deaths among people aged 20–29 and 30–39 years in 2021, respectively. Interpretation: Across Canada, the burden of premature opioid-related deaths doubled between 2019 and 2021, representing more than one-quarter of deaths among younger adults. The disproportionate loss of life in this demographic group highlights the critical need for targeted prevention efforts.","PeriodicalId":10359,"journal":{"name":"CMAJ : Canadian Medical Association Journal","volume":"36 4","pages":"E469 - E476"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CMAJ : Canadian Medical Association Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1503/cmaj.231339","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The drug toxicity crisis continues to accelerate across Canada, with rapid increases in opioid-related harms following the onset of the COVID-19 pandemic. We sought to describe trends in the burden of opioid-related deaths across Canada throughout the pandemic, comparing these trends by province or territory, age, and sex. Methods: We conducted a repeated cross-sectional analysis of accidental opioid-related deaths between Jan. 1, 2019, and Dec. 31, 2021, across 9 Canadian provinces and territories using aggregated national data. Our primary measure was the burden of premature opioid-related death, measured by potential years of life lost. Our secondary measure was the proportion of all deaths attributable to opioids; we used the Cochrane–Armitage test for trend to compare proportions. Results: Between 2019 and 2021, the annual number of opioid-related deaths increased from 3007 to 6222 and years of life lost increased from 126 115 to 256 336 (from 3.5 to 7.0 yr of life lost per 1000 population). In 2021, the highest number of years of life lost was among males (181 525 yr) and people aged 30–39 years (87 045 yr). In 2019, we found that 1.7% of all deaths among those younger than 85 years were related to opioids, rising to 3.2% in 2021. Significant increases in the proportion of deaths related to opioids were observed across all age groups (p < 0.001), representing 29.3% and 29.0% of deaths among people aged 20–29 and 30–39 years in 2021, respectively. Interpretation: Across Canada, the burden of premature opioid-related deaths doubled between 2019 and 2021, representing more than one-quarter of deaths among younger adults. The disproportionate loss of life in this demographic group highlights the critical need for targeted prevention efforts.
加拿大 9 个省和地区 2019 年至 2021 年阿片类药物相关死亡人数
背景:药物毒性危机继续在加拿大各地加速发展,在 COVID-19 大流行开始后,与阿片类药物相关的危害迅速增加。我们试图描述整个大流行期间加拿大阿片类药物相关死亡负担的趋势,并按省或地区、年龄和性别对这些趋势进行比较。方法:我们利用全国汇总数据对加拿大 9 个省和地区在 2019 年 1 月 1 日至 2021 年 12 月 31 日期间与阿片类药物相关的意外死亡进行了重复横断面分析。我们的主要衡量指标是阿片类药物相关过早死亡的负担,以潜在生命损失年数来衡量。我们的次要衡量标准是阿片类药物导致的死亡占所有死亡的比例;我们使用 Cochrane-Armitage 趋势检验来比较比例。结果从 2019 年到 2021 年,每年与阿片类药物相关的死亡人数从 3007 人增加到 6222 人,生命损失年数从 126 115 年增加到 256 336 年(每 1000 人的生命损失年数从 3.5 年增加到 7.0 年)。2021 年,男性(181 525 年)和 30-39 岁人群(87 045 年)的生命损失年数最高。我们发现,2019 年,在 85 岁以下人群的所有死亡案例中,有 1.7% 与阿片类药物有关,2021 年这一比例将上升至 3.2%。在所有年龄组中,与阿片类药物相关的死亡比例都出现了显著增长(p < 0.001),2021 年,在 20-29 岁和 30-39 岁人群中,与阿片类药物相关的死亡比例分别为 29.3% 和 29.0%。解释:在加拿大全国范围内,与阿片类药物相关的过早死亡人数在2019年至2021年间翻了一番,占年轻成年人死亡人数的四分之一以上。这一人口群体过多的生命损失凸显了开展有针对性的预防工作的迫切需要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信